Identifying The Machinery That Translocates Toxoplasma Effectors Into The Host Cell

识别将弓形虫效应器转移到宿主细胞中的机制

基本信息

  • 批准号:
    10215484
  • 负责人:
  • 金额:
    $ 54.53万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2018
  • 资助国家:
    美国
  • 起止时间:
    2018-08-09 至 2023-07-31
  • 项目状态:
    已结题

项目摘要

Abstract The major pathogenic species of Apicomplexa are all intracellular eukaryotic parasites that generally reproduce within a parasitophorous vacuole (PV) in infected host cells. This niche presents both an opportunity and a challenge to the parasites growing within – on the one hand, they are sequestered from some of the immune defenses that might detect their presence but at the same time, the PV membrane (PVM) presents a physical barrier to the export of protein effectors necessary to modulate host functions to the parasite's advantage. The phylum Apicomplexa includes many important human and animal pathogens including Plasmodium sp., the cause of human malaria, Cryptosporidium parvum, the cause of debilitating diarrheal disease, and Toxoplasma gondii, the cause of serious neurologic disease in the developing fetus and those who are immunocompromised through cancer (e.g., lymphoma), transplantation or infections, such as HIV-AIDS. We have recently determined that Toxoplasma tachyzoites have the ability to dramatically and specifically up-regulate expression of the human oncogene, c-Myc, using an effector released from dense granules, called GRA16. Using a genetic screen for mutants defective in c-Myc up-regulation, we have also recently identified the first components of the Toxoplasma machinery that translocates GRA16 and other dense granule effectors across the PVM. These novel proteins have been dubbed MYR1, MYR2 and MYR3. The goal of the work proposed here is to identify the complete or near complete machinery involved in translocation of effectors across the PVM, determine the host responses that are dependent on this machinery, and elucidate the importance of these effectors in Toxoplasma pathogenesis. We will do this through using a combination of biochemical and genetic approaches. Through this work, we will both unveil an important and novel piece of cell biology and identify crucial parasite components for eventual chemotherapeutic targeting and amelioration of the disease caused by this and related parasites.
摘要

项目成果

期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Toxoplasma Uses GRA16 To Upregulate Host c-Myc.
弓形虫利用 GRA16 上调宿主 c-Myc。
  • DOI:
    10.1128/msphere.00402-20
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Panas,MichaelW;Boothroyd,JohnC
  • 通讯作者:
    Boothroyd,JohnC
Erratum for Franco et al., "A Novel Secreted Protein, MYR1, Is Central to Toxoplasma's Manipulation of Host Cells".
Franco 等人的勘误表,“一种新型分泌蛋白,MYR1,是弓形虫操纵宿主细胞的核心”。
  • DOI:
    10.1128/mbio.01869-18
  • 发表时间:
    2018
  • 期刊:
  • 影响因子:
    6.4
  • 作者:
    Franco,Magdalena;Panas,MichaelW;Marino,NicoleD;Lee,Mei-ChongWendy;Buchholz,KerryR;Kelly,FeliceD;Bednarski,JeffreyJ;Sleckman,BarryP;Pourmand,Nader;Boothroyd,JohnC
  • 通讯作者:
    Boothroyd,JohnC
Translocation of Dense Granule Effectors across the Parasitophorous Vacuole Membrane in Toxoplasma-Infected Cells Requires the Activity of ROP17, a Rhoptry Protein Kinase.
致密颗粒效应器在弓形虫感染细胞中穿过寄生液泡膜的易位需要 ROP17(一种棒状体蛋白激酶)的活性。
  • DOI:
    10.1128/msphere.00276-19
  • 发表时间:
    2019
  • 期刊:
  • 影响因子:
    4.8
  • 作者:
    Panas,MichaelW;Ferrel,Abel;Naor,Adit;Tenborg,Elizabeth;Lorenzi,HernanA;Boothroyd,JohnC
  • 通讯作者:
    Boothroyd,JohnC
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

John C Boothroyd其他文献

John C Boothroyd的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('John C Boothroyd', 18)}}的其他基金

Identifying The Machinery That Translocates Toxoplasma Effectors Into The Host Cell
识别将弓形虫效应器转移到宿主细胞中的机制
  • 批准号:
    9761426
  • 财政年份:
    2018
  • 资助金额:
    $ 54.53万
  • 项目类别:
Role of Pseudouridylation in Toxoplasma Differentiation
假尿苷化在弓形虫分化中的作用
  • 批准号:
    8981871
  • 财政年份:
    2015
  • 资助金额:
    $ 54.53万
  • 项目类别:
Role of c-Myc up-regulation in Toxoplasma infection
c-Myc 上调在弓形虫感染中的作用
  • 批准号:
    8845424
  • 财政年份:
    2014
  • 资助金额:
    $ 54.53万
  • 项目类别:
Phosphoproteome of Toxoplasma
弓形虫磷酸化蛋白质组
  • 批准号:
    8416302
  • 财政年份:
    2012
  • 资助金额:
    $ 54.53万
  • 项目类别:
Phosphoproteome of Toxoplasma
弓形虫磷酸化蛋白质组
  • 批准号:
    8224139
  • 财政年份:
    2012
  • 资助金额:
    $ 54.53万
  • 项目类别:
A Stanford - SJSU Postdoctoral Training Program to Enhance URM Teaching
斯坦福大学 - SJSU 博士后培训计划以加强 URM 教学
  • 批准号:
    8733706
  • 财政年份:
    2010
  • 资助金额:
    $ 54.53万
  • 项目类别:
A Stanford - SJSU Postdoctoral Training Program to Enhance URM Teaching
斯坦福大学 - SJSU 博士后培训计划以加强 URM 教学
  • 批准号:
    9321785
  • 财政年份:
    2010
  • 资助金额:
    $ 54.53万
  • 项目类别:
Strain-specific Host-Pathogen Interactions in Toxoplasmosis
弓形虫病中菌株特异性宿主-病原体相互作用
  • 批准号:
    8696759
  • 财政年份:
    2007
  • 资助金额:
    $ 54.53万
  • 项目类别:
Strain-specific host-pathogen interactions in toxoplasmosis
弓形体病中菌株特异性宿主-病原体相互作用
  • 批准号:
    7900454
  • 财政年份:
    2007
  • 资助金额:
    $ 54.53万
  • 项目类别:
Strain-specific Host-Pathogen Interactions in Toxoplasmosis
弓形体病中菌株特异性宿主-病原体相互作用
  • 批准号:
    8611989
  • 财政年份:
    2007
  • 资助金额:
    $ 54.53万
  • 项目类别:

相似海外基金

RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    10219039
  • 财政年份:
    2020
  • 资助金额:
    $ 54.53万
  • 项目类别:
RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9981476
  • 财政年份:
    2019
  • 资助金额:
    $ 54.53万
  • 项目类别:
IGF::OT::IGF RESEARCH SUPPORT SERVICES FOR THE DIVISION OF ACQUIRED IMMUNODEFICIENCY SYNDROME
IGF::OT::IGF 针对获得性免疫缺陷综合症分类的研究支持服务
  • 批准号:
    9364184
  • 财政年份:
    2016
  • 资助金额:
    $ 54.53万
  • 项目类别:
Human Immunodeficiency Virus (HIV) and Acquired Immunodeficiency Syndrome (AIDS) in Saskatchewan- Where are we now and what does the future hold?
萨斯喀彻温省的人类免疫缺陷病毒(HIV)和获得性免疫缺陷综合症(艾滋病)——我们现在在哪里以及未来会怎样?
  • 批准号:
    236932
  • 财政年份:
    2011
  • 资助金额:
    $ 54.53万
  • 项目类别:
    Miscellaneous Programs
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554155
  • 财政年份:
    1991
  • 资助金额:
    $ 54.53万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6766860
  • 财政年份:
    1991
  • 资助金额:
    $ 54.53万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW COMMI
获得性免疫缺陷综合症研究审查委员会
  • 批准号:
    3554156
  • 财政年份:
    1991
  • 资助金额:
    $ 54.53万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6256640
  • 财政年份:
    1991
  • 资助金额:
    $ 54.53万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME RESEARCH REVIEW
获得性免疫缺陷综合症研究综述
  • 批准号:
    2063342
  • 财政年份:
    1991
  • 资助金额:
    $ 54.53万
  • 项目类别:
ACQUIRED IMMUNODEFICIENCY SYNDROME REVIEW
获得性免疫缺陷综合症审查
  • 批准号:
    6091256
  • 财政年份:
    1991
  • 资助金额:
    $ 54.53万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了